Bristol-Myers Squibb Company Ce (CELG-RI)
Bristol-Myers Squibb Company Ce operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Princeton, NJ, US. The stock last traded at $0.11, up 0.28% on the session, giving a market capitalisation of $220.8M. On trailing twelve-month figures it carries a net margin of 26.5%. Its beta of -0.47 implies it has historically moved less than the broad market.
Bristol Myers Squibb Company (BMS) operates as a biopharmaceutical enterprise, managing the entire lifecycle of its therapeutic products, from initial discovery and development to manufacturing, marketing, and distribution. Its diverse portfolio includes conventional small molecule drugs, advanced biologics (which are derived from biological processes), and specialized chimeric antigen receptor (CAR-T) cell therapies. The company was established in August 1933 and maintains its corporate headquarters in Princeton, New Jersey.
Bristol-Myers Squibb Company Ce is most often compared with the following Healthcare names: